Taiwan FDA registration 5a317273c70c47e684a57e81b26df666

SIEMENS INNOVANCE Antithrombin

TW: 西門子伊諾凡司抗凝血酶試劑
Taiwan flagTaiwan·Risk Class 2·MD·SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Registered Nov 15, 2017 – Nov 15, 2027Active
Registration details
Analysis ID
5a317273c70c47e684a57e81b26df666
License Form
Ministry of Health Medical Device Import No. 030455
Customs Code
DHA05603045502
Company information
Manufacturer Country
Germany
Authorized Representative
SYSMEX TAIWAN CO., LTD.
Product details
Intended Use
This product is a chromogenic assay for the automated quantitative detection of functionally active antithrombin in human citrate human plasma.
Product Type (Level 1)
B Hematology and pathology devices
Product Type (Level 2)
B7060 Anticoagulant III analysis
Import Information
Imported from abroad
Dates and status
Registration Date
Nov 15, 2017
Expiry Date
Nov 15, 2027
About this record

Access comprehensive regulatory information for SIEMENS INNOVANCE Antithrombin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5a317273c70c47e684a57e81b26df666 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices